SHARPE
Reported results
- Third quarter 2026 net income attributable to stockholders was $62.7 million, or $0.49 per diluted share, compared to $24.7 million, or $0.20 per diluted share, in Q3 2025.
- Third quarter 2026 total revenues were $193,088 thousand compared to $182,669 thousand in Q3 2025.
- Third quarter 2026 Nareit FFO attributable to stockholders and OP unit holders was $98.0 million, or $0.69 per diluted share, compared to $89.3 million, or $0.64 per diluted share, in Q3 2025.
- Third quarter 2026 Core FFO attributable to stockholders and OP unit holders was $100.7 million, or $0.71 per diluted share, compared to $90.6 million, or $0.65 per diluted share, in Q3 2025.
- Third quarter 2026 same-center NOI increased 5.3% to $122.4 million compared to $116.2 million during Q3 2025.
Guidance
- Updated full year 2026 diluted net income per share guidance is $1.21 to $1.24.
- Updated full year 2026 diluted Nareit FFO per share guidance is $2.68 to $2.72.
- Updated full year 2026 diluted Core FFO per share guidance is $2.75 to $2.79.
- Updated full year 2026 Same-Center NOI growth guidance is 3.50% to 4.00%.
- Full year 2026 gross acquisitions guidance reflects a range of $600 million to $700 million.
Price and volatility reaction
The stock moved -1.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -9.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 38.6 | 2026-10-26 |
| Close after release | 38.19 | 2026-10-27 |
| Realised move | -1.1% | close to close |
| 30d ATM IV change | -9.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-26 (8-K, Item 2.02). Read the original filing on sec.gov.